In particular, lymphocyte activating 3 (LAG3), T cell membrane protein 3 (TIM3), and T cell immunoglobulin and ITIM domain (TIGIT) co-inhibitory receptor have been proposed as prognostic markers in BC, together with CD47 [78,79,80]. Here, HAVCR2 is linked to breast cancer.